Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections | Diabetes Technology & Therapeutics
Glucose Meters | AgaMatrix
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial | Diabetes Technology & Therapeutics
Improving HbA1c levels with advanced hybrid closed-loop therapy - The Lancet Diabetes & Endocrinology
WaveForm Technologies Inc Awarded CE Mark Approval
Update and Advances in Technology For Diabetes Self Management PDF | PDF | Diabetes Mellitus | Mobile App
Bayer, WaveForm in tie-up for glucose monitoring solutions for China - Chinadaily.com.cn
AgaMatrix & WaveForm Complete $56 Million Capital Raise
Reorganization, and Formation of WaveForm Technologies Inc.
Glucose Meters | AgaMatrix
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
Opportunities and challenges in closed-loop systems in type 1 diabetes - The Lancet Diabetes & Endocrinology
Glucose Meters | AgaMatrix
Glucose Meters | AgaMatrix
Reorganization, and Formation of WaveForm Technologies Inc.
PCSK9 inhibition in children with familial hypercholesterolaemia
Wavesense Presto - Agamatrix - 8000-03329 - Blood Glucose Test Strips | StomaBags.com
WaveForm Gets Favorable Decision on Glucose Monitoring Patents
AgaMatrix | Innovative Products for Diabetes Care
AgaMatrix | Innovative Products for Diabetes Care
Comparison of Automated Insulin Delivery Systems - Diabetesnet.com
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
AgaMatrix Announces Reorganization, and Formation of WaveForm Technologies Inc.
